I'm going to need see some numbers on this statement. Because from where I'm sitting, the potential market is every human on planet earth, which is a pretty large amount of sales.
Production costs of mRNA vaccines, as well, is quite low, with much of the cost spent so far spent on scaling.
I'm going to need see some numbers on this statement. Because from where I'm sitting, the potential market is every human on planet earth, which is a pretty large amount of sales.
Production costs of mRNA vaccines, as well, is quite low, with much of the cost spent so far spent on scaling.